CD40 ligand (CD40L) signaling regulates ED via immune cell recruitment and platelet activation in mouse models of hypertension, the mechanism of which extended to mouse models of obesity, implicating CD40L as a therapeutic target for lipid dysmetabolism (36). Here, CD40LG is linked to Hypertension.